Selective lentiviral-mediated suppression of microRNA124a in the hippocampus evokes antidepressants-like effects in rats

Psychoneuroendocrinology

Volumn 46, Issue , 2014, Pages 78-87

  Bahi, Amine ^a   Chandrasekar, Vijay ^b   Dreyer, Jean Luc ^c  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

BDNF; Depression; Lentiviral vector; MicroRNAs; MiR124a; Social defeat stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LENTIVIRUS VECTOR; MICRORNA 124; MICRORNA 124A; SIRNA 124A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MICRORNA; MIRN124 MICRORNA, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; DOWN REGULATION; EVOKED RESPONSE; FEEDING BEHAVIOR; FORCED SWIM TEST; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL STRESS; SUCROSE PREFERENCE TEST; UPREGULATION; ANHEDONIA; ANIMAL; ANTAGONISTS AND INHIBITORS; EATING; GENE VECTOR; GENETICS; LENTIVIRINAE; MENTAL STRESS; METABOLISM; PLASMID; PSYCHOLOGY; SWIMMING; VIROLOGY; WISTAR RAT;

ANHEDONIA; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; EATING; GENETIC VECTORS; HIPPOCAMPUS; LENTIVIRUS; MALE; MICRORNAS; PLASMIDS; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84901398115     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.04.009     Document Type: Article

References (49)

1. Acheson A., Conover J.C., Fandl J.P., DeChiara T.M., Russell M., Thadani A., Squinto S.P., Yancopoulos G.D., Lindsay R.M. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 1995, 374:450-453.
2. Alfonso J., Frick L.R., Silberman D.M., Palumbo M.L., Genaro A.M., Frasch A.C. Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biol. Psychiatry 2006, 59:244-251.
3. Bahi A., Boyer F., Bussard G., Dreyer J.L. Silencing dopamine D3-receptors in the nucleus accumbens shell in vivo induces changes in cocaine-induced hyperlocomotion. Eur. J. Neurosci. 2005, 21:3415-3426.
4. Bahi A., Boyer F., Chandrasekar V., Dreyer J.L. Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats. Psychopharmacology 2008, 199:169-182.
5. Bahi A., Dreyer J.L. Hippocampus-specific deletion of tissue plasminogen activator tPA in adult mice impairs depression- and anxiety-like behaviors. Eur. Neuropsychopharmacol. 2012, 22:672-682.
6. Bahi A., Dreyer J.L. Striatal modulation of BDNF expression using microRNA124a-expressing lentiviral vectors impairs ethanol-induced conditioned-place preference and voluntary alcohol consumption. Eur. J. Neurosci. 2013, 38:2328-2337.
7. Bahi A., Kusnecov A.W., Dreyer J.L. Effects of urokinase-type plasminogen activator in the acquisition, expression and reinstatement of cocaine-induced conditioned-place preference. Behav. Brain Res. 2008, 191:17-25.
8. Balaratnasingam S., Janca A. Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders. Pharmacol. Ther. 2012, 134:116-124.
9. Bodnoff S.R., Suranyi-Cadotte B., Quirion R., Meaney M.J. A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology 1989, 97:277-279.
10. Cao X., Pfaff S.L., Gage F.H. A functional study of miR-124 in the developing neural tube. Genes Dev. 2007, 21:531-536.
11. Castren E., Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev. Neurobiol. 2010, 70:289-297.
12. Castren E., Voikar V., Rantamaki T. Role of neurotrophic factors in depression. Curr. Opin. Pharmacol. 2007, 7:18-21.
13. Chandrasekar V., Dreyer J.L. microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol. Cell. Neurosci. 2009, 42:350-362.
14. Chandrasekar V., Dreyer J.L. Regulation of MiR-124, Let-7d, and MiR-181a in the accumbens affects the expression, extinction, and reinstatement of cocaine-induced conditioned place preference. Neuropsychopharmacology 2011, 36:1149-1164.
15. D'Sa C., Duman R.S. Antidepressants and neuroplasticity. Bipolar Disord. 2002, 4:183-194.
16. Duman C.H., Schlesinger L., Kodama M., Russell D.S., Duman R.S. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol. Psychiatry 2007, 61:661-670.
17. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
18. Govindarajan A., Rao B.S., Nair D., Trinh M., Mawjee N., Tonegawa S., Chattarji S. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:13208-13213.
19. Haenisch B., Bilkei-Gorzo A., Caron M.G., Bonisch H. Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. J. Neurochem. 2009, 111:403-416.
20. Hendrickx H., McEwen B.S., Ouderaa F. Metabolism, mood and cognition in aging: the importance of lifestyle and dietary intervention. Neurobiol. Aging 2005, 26(Suppl. 1):1-5.
21. Hennebelle M., Balasse L., Latour A., Champeil-Potokar G., Denis S., Lavialle M., Gisquet-Verrier P., Denis I., Vancassel S. Influence of omega-3 fatty acid status on the way rats adapt to chronic restraint stress. PLoS ONE 2012, 7:e42142.
22. Huang Y.W., Ruiz C.R., Eyler E.C., Lin K., Meffert M.K. Dual regulation of miRNA biogenesis generates target specificity in neurotrophin-induced protein synthesis. Cell 2012, 148:933-946.
23. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M., Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol. Psychiatry 2005, 57:1068-1072.
24. Komatsu H., Ohara A., Sasaki K., Abe H., Hattori H., Hall F.S., Uhl G.R., Sora I. Decreased response to social defeat stress in mu-opioid-receptor knockout mice. Pharmacol. Biochem. Behav. 2011, 99:676-682.
25. Korte S.M., Smit J., Bouws G.A., Koolhaas J.M., Bohus B. Behavioral and neuroendocrine response to psychosocial stress in male rats: the effects of the 5-HT 1A agonist ipsapirone. Horm. Behav. 1990, 24:554-567.
26. Lindholm J.S., Autio H., Vesa L., Antila H., Lindemann L., Hoener M.C., Skolnick P., Rantamaki T., Castren E. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf(+)/(-) heterozygous null mice. Neuropharmacology 2012, 62:391-397.
27. Makeyev E.V., Zhang J., Carrasco M.A., Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 2007, 27:435-448.
28. Martinez M., Calvo-Torrent A., Herbert J. Mapping brain response to social stress in rodents with c-fos expression: a review. Stress 2002, 5:3-13.
29. Masi G., Brovedani P. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. CNS Drugs 2011, 25:913-931.
30. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
31. O'Connor R.M., Grenham S., Dinan T.G., Cryan J.F. microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus. Int. J. Neuropsychopharmacol. 2013, 16:1885-1892.
32. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego.
33. Pizarro J.M., Lumley L.A., Medina W., Robison C.L., Chang W.E., Alagappan A., Bah M.J., Dawood M.Y., Shah J.D., Mark B., Kendall N., Smith M.A., Saviolakis G.A., Meyerhoff J.L. Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res. 2004, 1025:10-20.
34. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977, 229:327-336.
35. Qi L., Hu Y., Zhan Y., Wang J., Wang B.B., Xia H.F., Ma X. A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer's disease in a Mongolian population. Neurosci. Lett. 2012, 515:1-6.
36. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., Agerman K., Haapasalo A., Nawa H., Aloyz R., Ernfors P., Castren E. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 2003, 23:349-357.
37. Schinder A.F., Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci. 2000, 23:639-645.
38. Schmidt H.D., Duman R.S. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 2010, 35:2378-2391.
39. Schmidt H.D., Shelton R.C., Duman R.S. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 2011, 36:2375-2394.
40. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64:527-532.
41. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002, 22:3251-3261.
42. Sofia R.D., Knobloch L.C. Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats. Pharmacol. Biochem. Behav. 1976, 4:591-599.
43. Soppet D., Escandon E., Maragos J., Middlemas D.S., Reid S.W., Blair J., Burton L.E., Stanton B.R., Kaplan D.R., Hunter T., Nikolics K., Parada L.F. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 1991, 65:895-903.
44. Treiber T., Treiber N., Meister G. Regulation of microRNA biogenesis and function. Thromb. Haemost. 2012, 107:605-610.
45. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 2006, 9:519-525.
46. Yamada K., Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 2003, 91:267-270.
47. Yang L., Engeland C.G., Cheng B. Social isolation impairs oral palatal wound healing in Sprague-Dawley rats: a role for miR-29 and miR-203 via VEGF suppression. PLoS ONE 2013, 8:e72359.
48. Zigova T., Pencea V., Wiegand S.J., Luskin M.B. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol. Cell. Neurosci. 1998, 11:234-245.
49. Zurita A., Murua S., Molina V. An endogenous opiate mechanism seems to be involved in stress-induced anhedonia. Eur. J. Pharmacol. 1996, 299:1-7.